###begin article-title 0
Phosphorylation Regulates SIRT1 Function
###end article-title 0
###begin p 1
Conceived and designed the experiments: TS BM TS HS. Performed the experiments: TS BM KK MC WG. Analyzed the data: TS BM MC TS WM HS. Contributed reagents/materials/analysis tools: TS WM. Wrote the paper: TS HS.
###end p 1
###begin p 2
Current address: Laboratory of Metabolic Signal, Institute for Molecular and Cellular Regulation, Gunma University, Maebashi, Gunma, Japan
###end p 2
###begin p 3
Current address: Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, Indiana, United States of America
###end p 3
###begin title 4
Background
###end title 4
###begin p 5
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SIR2</italic>
###xml 14 15 14 15 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 38 41 38 41 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004020-Imai1">[1]</xref>
###xml 42 45 42 45 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004020-Smith1">[3]</xref>
###xml 118 121 118 121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004020-Kaeberlein1">[4]</xref>
###xml 129 132 129 132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004020-Tissenbaum1">[5]</xref>
###xml 144 147 144 147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004020-Rogina1">[6]</xref>
###xml 229 232 229 232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004020-Frye1">[7]</xref>
###xml 234 237 234 237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004020-Frye2">[8]</xref>
###xml 297 305 297 305 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 310 317 310 317 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 317 320 317 320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004020-Sasaki1">[9]</xref>
###xml 663 667 663 667 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004020-Yang1">[10]</xref>
###xml 746 750 746 750 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004020-Beausoleil1">[11]</xref>
###xml 112 117 <span type="species:ncbi:4932">yeast</span>
###xml 344 348 <span type="species:ncbi:10090">mice</span>
###xml 382 386 <span type="species:ncbi:10090">mice</span>
SIR2 is an NAD+-dependent deacetylase [1]-[3] implicated in the regulation of lifespan in species as diverse as yeast [4], worms [5], and flies [6]. We previously reported that the level of SIRT1, the mammalian homologue of SIR2 [7], [8], is coupled to the level of mitotic activity in cells both in vitro and in vivo[9]. Cells from long-lived mice maintained SIRT1 levels of young mice in tissues that undergo continuous cell replacement by proliferating stem cells. Changes in SIRT1 protein level were not associated with changes in mRNA level, suggesting that SIRT1 could be regulated post-transcriptionally. However, other than a recent report on sumoylation [10] and identification of SIRT1 as a nuclear phospho-protein by mass spectrometry [11], post-translational modifications of this important protein have not been reported.
###end p 5
###begin title 6
Methodology/Principal Findings
###end title 6
###begin p 7
###xml 59 66 59 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 126 134 126 134 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 160 161 160 161 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 500 504 500 504 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004020-Cheng1">[12]</xref>
###xml 506 510 506 510 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004020-McBurney1">[13]</xref>
We identified 13 residues in SIRT1 that are phosphorylated in vivo using mass spectrometry. Dephosphorylation by phosphatases in vitro resulted in decreased NAD+-dependent deacetylase activity. We identified cyclinB/Cdk1 as a cell cycle-dependent kinase that forms a complex with and phosphorylates SIRT1. Mutation of two residues phosphorylated by Cyclin B/Cdk1 (threonine 530 and serine 540) disturbs normal cell cycle progression and fails to rescue proliferation defects in SIRT1-deficient cells [12], [13].
###end p 7
###begin title 8
Conclusions/Significance
###end title 8
###begin p 9
###xml 374 378 374 378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004020-Milne1">[14]</xref>
###xml 379 383 379 383 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004020-Baur1">[16]</xref>
###xml 729 733 729 733 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004020-Kim1">[17]</xref>
###xml 735 739 735 739 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004020-Zhao1">[18]</xref>
###xml 753 757 753 757 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004020-Kim2">[19]</xref>
###xml 137 141 <span type="species:ncbi:10090">mice</span>
###xml 508 513 <span type="species:ncbi:9606">human</span>
Pharmacological manipulation of SIRT1 activity is currently being tested as a means of extending lifespan in mammals. Treatment of obese mice with resveratrol, a pharmacological activator of SIRT1, modestly but significantly improved longevity and, perhaps more importantly, offered some protection against the development of type 2 diabetes mellitus and metabolic syndrome [14]-[16]. Understanding the endogenous mechanisms that regulate the level and activity of SIRT1, therefore, has obvious relevance to human health and disease. Our results identify phosphorylation by cell cycle dependent kinases as a major mechanism controlling the level and function of this sirtuin and complement recent reports of factors that inhibit [17], [18] and activate [19] SIRT1 by protein-protein interactions.
###end p 9
###begin title 10
Introduction
###end title 10
###begin p 11
###xml 4 8 4 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SIR2</italic>
###xml 28 29 28 29 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 52 55 52 55 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004020-Imai1">[1]</xref>
###xml 56 59 56 59 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004020-Smith1">[3]</xref>
###xml 138 142 138 142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004020-Rine1">[20]</xref>
###xml 234 238 234 238 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004020-Brachmann1">[21]</xref>
###xml 253 257 253 257 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SIR2</italic>
###xml 297 300 297 300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004020-Frye1">[7]</xref>
###xml 302 305 302 305 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004020-Frye2">[8]</xref>
###xml 307 312 307 312 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SIRT1</italic>
###xml 344 348 344 348 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SIR2</italic>
###xml 357 381 357 381 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Saccharomyces cerevisiae</italic>
###xml 381 384 381 384 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004020-Frye2">[8]</xref>
###xml 405 409 405 409 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SIR2</italic>
###xml 449 452 449 452 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004020-Kaeberlein1">[4]</xref>
###xml 520 523 520 523 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004020-Tissenbaum1">[5]</xref>
###xml 525 528 525 528 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004020-Rogina1">[6]</xref>
###xml 697 701 697 701 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004020-Lagouge1">[15]</xref>
###xml 703 707 703 707 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004020-Baur1">[16]</xref>
###xml 88 93 <span type="species:ncbi:4932">yeast</span>
###xml 227 233 <span type="species:ncbi:9606">humans</span>
###xml 290 296 <span type="species:ncbi:9606">humans</span>
###xml 357 381 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
###xml 443 448 <span type="species:ncbi:4932">yeast</span>
###xml 649 653 <span type="species:ncbi:10090">mice</span>
The SIR2 gene encodes an NAD+-dependent deacetylase [1]-[3]. It was first identified in yeast as a gene involved in mating type switching [20], but is now known to be a highly conserved gene in organisms ranging from archea to humans [21]. Of the seven SIR2 family homologues (sirtuins) in humans [7], [8], SIRT1 is most closely related to the SIR2 gene of Saccharomyces cerevisiae[8]. Over-expression of SIR2 extends replicative life-span in yeast [4], and orthologs extend organismal life-span in both worms and flies [5], [6]. Recently, it was shown that resveratrol, a pharmacological activator of SIRT1, can improve the life span and health of mice on a typical "western" (high-calorie) diet [15], [16].
###end p 11
###begin p 12
###xml 105 113 105 113 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 118 125 118 125 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 125 128 125 128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004020-Sasaki1">[9]</xref>
###xml 426 430 426 430 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004020-Beausoleil1">[11]</xref>
###xml 461 465 461 465 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004020-Yang1">[10]</xref>
We previously reported that the level of SIRT1 is coupled to the level of mitotic activity in cells both in vitro and in vivo[9]. Changes in SIRT1 protein level were not associated with changes in mRNA level, suggesting that SIRT1 could be regulated post-transcriptionally. However, other than phosphorylation of serine 27 and serine 47, which were detected in general screens of nuclear phospho-proteins by mass spectrometry [11] and sumoylation of lysine 734 [10], post-translational modifications of this important protein have not been reported.
###end p 12
###begin p 13
###xml 272 273 272 273 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 339 340 339 340 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 465 466 465 466 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 521 525 521 525 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004020-Nigg1">[22]</xref>
###xml 719 723 719 723 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004020-Pflum1">[23]</xref>
###xml 725 729 725 729 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004020-deRuijter1">[24]</xref>
In this work, we investigated the connection between SIRT1 protein levels and mitotic activity by determining if there was a direct effect of mitotic cell cycle kinases on SIRT1 phosphorylation. In somatic cells, cyclin D/Cdk 4,6 is active during the progression through G1 and into S phase. Cyclin E/Cdk 2 complex becomes active at late G1 phase into S phase. CyclinA/Cdk2 becomes active during S phase, and the CyclinB/Cdk1 complex is activated upon passing the G2/M checkpoint and inactivated upon entry into anaphase [22]. We also explored the hypothesis that phosphorylation might regulate the deacetylase activity of SIRT1, as it is known to do with other classes of protein deacetylases, such as HDAC1 and HDAC2 [23], [24]. As described below, we found that SIRT1 is phosphorylated by cyclinB/Cdk1, and that phosphorylation regulates its deacetylase activity and affects cell proliferation.
###end p 13
###begin title 14
Results
###end title 14
###begin title 15
###xml 39 46 39 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
SIRT1 is phosphorylated at 13 residues in vivo
###end title 15
###begin p 16
###xml 333 340 333 340 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 1A</bold>
###xml 333 340 333 340 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004020-g001"><bold>Fig. 1A</bold></xref>
To determine if SIRT1 is a phosphoprotein, we stained gels containing affinity-purified FLAG-SIRT1 separated by SDS-PAGE with Pro-Q Diamond phosphoprotein reagent. We also performed western analysis using an antibody that detects the phosphorylated serine residue in the consensus Cdk recognition motif (K/R-S*-P-x-K/R). As shown in Fig. 1A, both the anti-phospho serine Cdk substrate antibody and the ProQ reagent detect a protein that migrates to the same position in the gel as FLAG-SIRT1 (120 kD; lane marked "-"). The signals decreased in a dose-dependent manner following treatment with lambda protein phosphatase (lambdappase). Although reaction with the anti- phospho serine Cdk substrate antibody was lost at a low dose of lambdappase, some reactivity with the phosphoprotein stain, which detects all phospho-residues, was still visible even after treatment with high doses of lambdappase and required overnight treatment for complete removal. This difference in sensitivity to lambdappase treatment of the two detection methods implied that SIRT1 could be phosphorylated at multiple residues, and could contain phospho-threonine and phospho-tyrosine residues in addition to phospho-serine.
###end p 16
###begin title 17
SIRT1 is a phosphoprotein.
###end title 17
###begin p 18
###xml 558 565 543 550 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0004020-t001">Table 1</xref>
###xml 636 641 <span type="species:ncbi:9606">human</span>
A. Affinity-purified SIRT1 is phosphorylated, and can be dephosphorylated by lambdappase. Top panel, western blot of total SIRT1; middle panel, western blot of SIRT1 phosphorylated at the Cdk consensus site; bottom panel, ProQ-diamond stained blot showing total phosphorylated SIRT1. Numbers above the lanes indicate the relative doses of lambdappase used to treat FLAG-SIRT1 for 1 hour. Overnight treatment (O/N) was done with a 1/10 dilution of lambdappase. B. Schematic of the phosphorylated residues in SIRT1 identified by mass spectrometry, as shown in Table 1. P, phosphorylated residue. C. 3D structure prediction of full-length human SIRT1 with the positions of phosphorylated residues identified by mass spectrometry (red symbols). Amino terminal domain, green; catalytic core domain, blue; carboxy terminal domain, yellow. The Rossmann fold supporting the catalytic groove in the core domain is shown in red. The two mutated residues described in the text (Thr530 and Ser540) are indicated with asterisks.
###end p 18
###begin p 19
###xml 58 65 58 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 178 185 178 185 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table 1</bold>
###xml 178 185 178 185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0004020-t001"><bold>Table 1</bold></xref>
###xml 536 543 536 543 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 1B</bold>
###xml 536 543 536 543 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004020-g001"><bold>Fig. 1B</bold></xref>
###xml 780 789 780 789 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ab initio</italic>
###xml 858 865 858 865 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 1C</bold>
###xml 858 865 858 865 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004020-g001"><bold>Fig. 1C</bold></xref>
To identify the residues of SIRT1 that are phosphorylated in vivo, we analyzed affinity-purified FLAG-SIRT1 by mass spectrometry. The analysis revealed 13 phosphorylation sites (Table 1), including threonine 530 and serine 540. Phosphorylation was restricted to serine and threonine residues; there were no phosphorylated tyrosine residues in the samples examined. All of the identified phosphorylation sites are located in either the N-terminal domain or the C-terminal domain of SIRT1, and not in the conserved catalytic core domain (Fig. 1B). To illustrate how the phosphorylation sites could potentially regulate substrate access and protein interactions, we used the known amino acid sequence of SIRT to derive a full chain protein structure prediction based on homology and ab initio modeling using the Robetta server (Baker Laboratory, ). As shown in Fig. 1C, the structure predicts an extensive clustering of phosphorylation sites on residues in the carboxy terminal domain (yellow) adjacent to the Rossmann fold (red) that supports the catalytic groove in the core domain (blue). Phosphorylation of residues in the amino terminal domain (green) are less likely to be directly involved in regulating enzyme activity.
###end p 19
###begin title 20
Phospho-peptide mapping of FLAG-SIRT1 by mass spectrometry.
###end title 20
###begin p 21
Phosphorylation is indicated by an asterisk (*). A site that could not be ruled out is indicated by a question mark (?). Two independent samples of affinity-purified FLAG-SIRT1 were analyzed. The results were consistent between the two, except for S747 phosphorylation, which was detected in only one of the samples.
###end p 21
###begin title 22
Cyclin recognition motifs and Cdk substrate residues are conserved among orthologs of SIRT1
###end title 22
###begin p 23
###xml 207 214 207 214 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table 2</bold>
###xml 207 214 207 214 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0004020-t002"><bold>Table 2</bold></xref>
###xml 261 268 261 268 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table 1</bold>
###xml 261 268 261 268 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0004020-t001"><bold>Table 1</bold></xref>
###xml 513 517 513 517 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004020-Takeda1">[25]</xref>
###xml 671 675 671 675 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004020-Songyang1">[26]</xref>
###xml 676 680 676 680 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004020-Zhang1">[28]</xref>
To determine if the phosphorylation sites identified by mass spectrometry were evolutionarily conserved, we compared the amino acid sequences surrounding each phosphorylated residue in 12 different species (Table 2). Among the phosphorylated residues listed in Table 1, Ser159, Ser162, Ser172, Ser173, Thr530, Ser535, Ser538, and Ser540 are relatively well conserved. A cyclin recognition motif and a Cdk substrate motif together constitute a bipartite substrate recognition sequence for cyclin-dependent kinases [25]. Ser540 fits the full consensus sequence for a Cdk substrate (S/T*-P-x-K/R), and Thr530 fits the minimal consensus sequence for a Cdk substrate (S/T*-P) [26]-[28]. Two cyclin recognition motifs (located between amino acid 203-207 and 519-523) are also well conserved. Some of the phosphorylation sites are not conserved because the N-terminal and the C-terminal domains are not present in orthologs of SIRT1 in lower organisms. Other sites that fit the minimal consensus sequence for Cdk substrates, such as Ser14, Ser26/27, Ser47 and Ser545, are only conserved in higher organisms.
###end p 23
###begin title 24
Conservation of phosphorylated residues, cyclin recognition motifs, and Cdk substrate motifs among SIRT1 orthologs of 12 different species.
###end title 24
###begin p 25
###xml 171 176 <span type="species:ncbi:9606">human</span>
Comparison of SIRT1 sequences by "BLAST 2 Sequence" among species, in which the protein sequence of the SIRT1 ortholog was available. Listed in order of the similarity to human SIRT1, from top to bottom. For species for which ELM motif data were available (BOLD), motif conservation was analyzed as well. For cyclin recognition motif, "ok" stands for a complete conservation of the motif, "?" for a partial conservation, and "ng" for loss of conservation. SP (14-15, 26-28, 47-48, 545-546) and TP (530-531) fit the minimal Cdk substrate motif, and the sequence between amino acids 537-543 fits the full Cdk substrate motif.
###end p 25
###begin p 26
Abbreviations: cyc, cyclin recognition motif; Cdk, full Cdk-substrate motif.
###end p 26
###begin title 27
SIRT1 deacetylase activity is modulated by phosphorylation
###end title 27
###begin p 28
###xml 80 81 80 81 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 275 287 275 287 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fluor-de Lys</italic>
###xml 287 291 287 291 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004020-Howitz1">[29]</xref>
###xml 348 355 348 355 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 2A</bold>
###xml 348 355 348 355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004020-g002"><bold>Fig. 2A</bold></xref>
###xml 393 400 388 395 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 2B</bold>
###xml 393 400 388 395 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004020-g002"><bold>Fig. 2B</bold></xref>
###xml 1083 1084 1078 1079 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1156 1168 1151 1163 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fluor-de Lys</italic>
###xml 1208 1209 1203 1204 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1223 1230 1218 1225 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 2C</bold>
###xml 1223 1230 1218 1225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004020-g002"><bold>Fig. 2C</bold></xref>
###xml 1317 1318 1312 1313 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 314 318 <span type="species:ncbi:9913">calf</span>
To test the possibility that the phosphorylation of SIRT1 might modulate its NAD+-dependent deacetylase activity, we compared the enzymatic activity of phosphorylated and dephosphorylated affinity-purified FLAG-SIRT1 using a fluorogenic peptide-substrate-based assay system, Fluor-de Lys[29]. Dephosphorylation by calf intestinal phosphatase (CIP; Fig. 2A) or lambda phosphatase (lambdappase; Fig. 2B) led to a decline in deacetylase activity. This decline was associated with complete dephosphorylation at the Cdk sites in SIRT1, as shown in the accompanying images of western blots analyzed with an antibody against phosphorylated Cdk recognition sites. Neither the deacetylase activity nor the reaction with the anti-phosphoserine Cdk substrate antibody decreased when phosphatase activities were blocked (lanes marked "+inhibitor"). Therefore, the general loss of SIRT1 phosphorylation leads to a decline in its deacetylase activity. To rule out the possibility that changes in deacetylase activity were due to the activity of other classes of histone deacetylases, which are NAD+-independent, contaminating the FLAG-SIRT1 preparation, we repeated the Fluor-de Lys deacetylase assay in the absence of NAD+. As shown in Fig. 2C, there was no measurable deacetylase activity in the FLAG-SIRT1 preparation unless NAD+ was added to the reaction.
###end p 28
###begin title 29
###xml 3 4 3 4 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
NAD+-dependent deacetylase activity of SIRT1 is modulated by phosphorylation.
###end title 29
###begin p 30
###xml 8 9 8 9 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 419 420 414 415 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 554 555 549 550 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
A/B. NAD+-dependent deacetylase activity of SIRT1 in the presence of CIP (A) or lambdappase (B) with or without phosphatase inhibitors. Western blots below each bar graph indicate the amount of SIRT1 in the reaction (top panel) and the degree of SIRT1 phosphorylation represented by Cdk-pSer signal (bottom panel). C. Deacetylase activity of affinity-purified FLAG-SIRT1 in the presence (left) or absence (right) of NAD+. Blue bars, no nicotinamide added; red bars, + nicotinamide. *, p<0.005; **, p<0.02; ***, p<0.002; #, p<0.01; ##, p<0.001 (Student's t-test). Error bars indicate +/-SEM.
###end p 30
###begin title 31
###xml 44 51 44 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
SIRT1 forms a complex with cyclinB and Cdk1 in vivo
###end title 31
###begin p 32
###xml 123 130 123 130 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 446 453 446 453 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 3A</bold>
###xml 446 453 446 453 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004020-g003"><bold>Fig. 3A</bold></xref>
###xml 544 548 544 548 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004020-Nigg1">[22]</xref>
###xml 670 677 670 677 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 3A</bold>
###xml 670 677 670 677 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004020-g003"><bold>Fig. 3A</bold></xref>
###xml 847 854 847 854 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 3A</bold>
###xml 847 875 847 875 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004020-g003"><bold>Fig. 3A</bold>, lanes marked &#8220;ProG&#8221;</xref>
###xml 1559 1566 1559 1566 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 3B</bold>
###xml 1559 1566 1559 1566 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004020-g003"><bold>Fig. 3B</bold></xref>
###xml 1859 1866 1859 1866 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 3B</bold>
###xml 1859 1887 1859 1887 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004020-g003"><bold>Fig. 3B</bold>, lanes marked &#8220;ProG&#8221;</xref>
To determine if the highly conserved cyclin/Cdk substrate motifs at Thr530 and Ser540, which we found to be phosphorylated in vivo, are substrates for the enzyme, we transfected 293T cells with a FLAG-SIRT1 expression vector and prepared cell lysates from cells in exponential growth phase. We immunoprecipitated SIRT1 using anti-FLAG M2 beads and analyzed the immune complexes by western blot. We found Cdk1 in immune complexes with FLAG-SIRT1 (Fig. 3A). Cdk1 is a G2/M phase kinase that interacts with cyclinA and cyclinB to regulate mitosis [22]. We found that cyclinB, but not cyclinA, was detectable in a complex with FLAG-SIRT1 in asynchronously growing cultures (Fig. 3A). This interaction was specific, as no cyclin or Cdk proteins were immunoprecipitated when non-specific protein-G beads were substituted for the FLAG M2-specific beads (Fig. 3A, lanes marked "ProG"). The relatively low percentage of cyclinB detected in immune complexes reflects the relatively small number of cells in M-phase in these cultures, which could account for our inability to detect cyclinA in immune complexes with SIRT1 and Cdk1 as well. It is also possible that G1-associated kinases, such as Cdk2, Cdk4 and Cdk6, interact with SIRT1 at levels we could not detect, but this is less likely due to the relative abundance of cells in G1even in asynchronized cultures. Next, we performed co-immunoprecipitations from extracts of embryonic stem cells (ESCs) to determine if complexes between SIRT1 and Cdk1 and cyclinB also formed between endogenous proteins. As shown in Fig. 3B, antibodies against both N- and C-terminal epitopes of SIRT1 precipitated endogenous Cdk1 and cyclinB along with endogenous Sirt1 in ESCs. This interaction was specific, as no proteins were immunoprecipitated when non-specific protein-G beads were substituted for the FLAG M2-specific beads (Fig. 3B, lanes marked "ProG"). Compared to MEFs, a higher proportion of cyclinB was co-precipitated with SIRT1, reflecting the high proportion of ESCs that are in M-phase even in asynchronously growing cultures.
###end p 32
###begin title 33
SIRT1 forms a complex with cyclinB/Cdk1.
###end title 33
###begin p 34
A. Western blot analysis of different Cdks and Cyclins following co-IP with FLAG-SIRT1. Complex formations of FLAG-SIRT1 with Cdk1 and cyclinB were detected, but not with Cdk2, Cdk4, Cdk6, or cyclinA. Amounts of samples used: whole cell extract (WCE), 20 microg; IP 500 microg. B. Western blot of co-IP experiments with endogenous SIRT1, which also forms a complex with Cdk1 and cyclinB. Amounts of samples used: WCE, 20 microg; IP 1.5 mg. WCE, whole cell extracts; IP, immunoprecipitation; FLAG, FLAG-M2 beads.
###end p 34
###begin title 35
###xml 40 48 40 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
SIRT1 is phosphorylated by cyclinB/Cdk1 in vitro
###end title 35
###begin p 36
###xml 69 77 69 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 292 300 292 300 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 302 311 302 311 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 4A&#8211;B</bold>
###xml 302 311 302 311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004020-g004"><bold>Fig. 4A&#8211;B</bold></xref>
###xml 1059 1066 1054 1061 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 5A</bold>
###xml 1059 1066 1054 1061 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004020-g005"><bold>Fig. 5A</bold></xref>
###xml 1263 1271 1258 1266 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1477 1484 1467 1474 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 5C</bold>
###xml 1477 1484 1467 1474 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004020-g005"><bold>Fig. 5C</bold></xref>
###xml 1901 1905 1886 1890 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004020-Li1">[30]</xref>
###xml 2017 2024 2002 2009 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 5C</bold>
###xml 2017 2024 2002 2009 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004020-g005"><bold>Fig. 5C</bold></xref>
###xml 115 120 <span type="species:ncbi:9606">human</span>
To determine if cyclinB/Cdk1 could phosphorylate SIRT1, we performed in vitro kinase assays with affinity-purified human FLAG-SIRT1, using histone H1, a known substrate for cyclinB/Cdk1, as a positive control. We found that SIRT1 is an excellent substrate for phosphorylation by cyclinB/Cdk1 in vitro (Fig. 4A-B). We think that endogenous SIRT1 is also phosphorylated by this cyclin/cdk complex, although the reagents necessary to verify this experimentally are currently not available. Recombinant SIRT1, on the other hand, was a poor substrate (data not shown), probably reflecting a requirement for second-site phosphorylation, which would have been missing in this bacterially produced protein. To test the requirement for second-site phosphorylation directly, we subjected affinity-purified FLAG-SIRT1 to global dephosphorylation, then treated the dephosphorylated substrates with cyclinB/Cdk1. Phosphorylation at Cdk recognition sites in SIRT1 decreased as the dose of lambdappase increased, and was abolished when SIRT1 was maximally dephosphorylated (Fig. 5A). The level of phosphorylation at Cdk sites was higher in extracts with added cyclinB/Cdk1 than in extracts with no added kinase (compare left- and right-hand panels). Next, we performed a second in vitro kinase assay using radioactive ATP to detect protein phosphorylation by cyclinB/Cdk1. After treatment with higher doses of lambdappase, there was minimal incorporation of radioactive phosphate into SIRT1 (Fig. 5C). Histone H1, however, which is not affected by second-site phosphorylation, was efficiently labeled by radioactive ATP even at the highest doses of lambdappase. These data imply that additional phosphorylation sites increase the suitability of SIRT1 as a substrate for cyclinB/Cdk1. To test this, we used a mitotic kinase mix, which contains high levels of several mitotic-phase kinases in addition to cyclinB/Cdk1 [30], to phosphorylate FLAG-SIRT1. In the presence of these additional kinases, SIRT1 was maximally phosphorylated (Fig. 5C).
###end p 36
###begin title 37
SIRT1 is phosphorylated by cyclinB/Cdk1 in vitro.
###end title 37
###begin p 38
###xml 232 235 232 235 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs.</italic>
A. Autoradiographs of radioactively labeled proteins separated by SDS-PAGE (upper panels) and pictures of Coomassie blue-stained gels (lower panels). Substrates are indicated to the left of each pair of panels. B. ATP incorporation vs. time. ATP incorporation was determined by scintillation counting of the radioactivity in each band.
###end p 38
###begin title 39
SIRT1 requires phosphorylation to become a suitable substrate for cyclinB/Cdk1 in vitro.
###end title 39
###begin p 40
###xml 306 314 301 309 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
A. Western blots of Cdk-phosphorylated (top panel) and total SIRT1 (bottom panel) following treatment with increasing doses of lambda phosphatase (lambdappase). The upper band corresponds to the full-length SIRT1. B. Levels of SIRT1 phosphorylation at Cdk-specific sites in extracts used as substrates for in vitro kinase assays shown in C. C. Autoradiographs (top panels) and Coomassie blue-stained gels (bottom panels) of SIRT1 and histone H1 phosphorylated by the kinases indicated on left. 0, 0.01, 0.1, 1, relative doses of lambdappase used; %P, relative percentage of Cdk phospho-serine signal compared to control.
###end p 40
###begin title 41
###xml 67 75 67 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
Threonine 530 and serine 540 of SIRT1 are targets for cyclinB/Cdk1 in vitro
###end title 41
###begin p 42
###xml 240 248 240 248 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 358 367 354 363 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 6A&#8211;B</bold>
###xml 358 367 354 363 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004020-g006"><bold>Fig. 6A&#8211;B</bold></xref>
###xml 579 588 575 584 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 6C&#8211;D</bold>
###xml 579 588 575 584 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004020-g006"><bold>Fig. 6C&#8211;D</bold></xref>
###xml 653 661 649 657 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 890 897 886 893 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table 2</bold>
###xml 890 897 886 893 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0004020-t002"><bold>Table 2</bold></xref>
###xml 939 947 935 943 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
To test the hypothesis that Thr530 and Ser540 are cyclinB/Cdk1 substrates directly, we mutated each site to a non-phosphorylatable amino acid (alanine), then tested whether or not the mutant proteins could be phosphorylated by cyclinB/Cdk1 in vitro. Mutation of either Ser540-->Ala or Thr530-->Ala or both had no effect on protein stability or localization (Fig. 6A-B). However, compared to wild type, the S540A mutant showed approximately 50% reduction in the incorporation of radioactive ATP and the T530A and T530A/S540A double mutant (AA) showed approximately 35% reduction (Fig. 6C-D), indicating that both residues are substrates for cyclinB/Cdk1 in vitro. The fact that the radioactive signal decreased in the mutants, but did not go away completely, indicates that other less well-conserved residues that fit the minimal Cdk substrate motif, such as Ser14, Ser27, Ser47 and Ser545 (Table 2) may also be substrates for cyclinB/Cdk1 in vitro.
###end p 42
###begin title 43
Threonine 530 and serine 540 of SIRT1 are substrates for cyclinB/Cdk1 in vitro.
###end title 43
###begin p 44
###xml 456 464 456 464 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vitro</italic>
###xml 553 561 553 561 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 749 752 749 752 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs.</italic>
A. Western blot analysis of nuclear (N) and cytoplasmic (C) fractions of cells transfected with FLAG-SIRT1 expression vectors encoding wild type (WT) and mutant SIRT1 proteins. Blots were subsequently reacted with antibodies against pericentrin and GAPDH to demonstrate the purity of the nuclear and cytoplasmic fractions, respectively. B. Western blot analysis of WT and mutant proteins in the presence and absence of the proteasome inhibitor MG132. C/D. In vitro kinase assays showing that threonine 530 and serine 540 are substrates for cyclinB/Cdk1 in vitro. The results are shown by autoradiograph (top panels) and Coomassie blue stained gel (bottom panels) in (C) and by the plot of ATP incorporation (as measured by scintillation countering) vs. time in (D).
###end p 44
###begin title 45
Phosphorylation of SIRT1 at Thr530 and Ser540 influences cell proliferation and cell cycle profiles
###end title 45
###begin p 46
###xml 331 332 331 332 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 856 859 856 859 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 866 873 866 873 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 7A</bold>
###xml 866 890 866 890 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004020-g007"><bold>Fig. 7A</bold>, left-hand panel</xref>
###xml 906 913 906 913 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 7B</bold>
###xml 906 930 906 930 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004020-g007"><bold>Fig. 7B</bold>, left-hand panel</xref>
###xml 1020 1029 1020 1029 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 7A&#8211;B</bold>
###xml 1020 1048 1020 1048 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004020-g007"><bold>Fig. 7A&#8211;B</bold>, right-hand panels</xref>
###xml 1191 1200 1191 1200 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 7C&#8211;D</bold>
###xml 1191 1200 1191 1200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004020-g007"><bold>Fig. 7C&#8211;D</bold></xref>
###xml 695 700 <span type="species:ncbi:10090">mouse</span>
To determine if the decline in deacetylase activity associated with global dephosphorylation of SIRT1 was linked to changes in phosphorylation at Thr530 and/or Ser540, we compared the deacetylase activity in preparations of FLAG-SIRT1 with or without the T530A and/or S540A mutations. We found no significant differences in the NAD+-dependent deacetylase activity (data not shown). However, another possible function of SIRT1 phosphorylation by cell cycle-regulated kinases was suggested by our previous finding that cell proliferation fluctuates with the level of SIRT1 in cells and tissues (Sasaki 2006). To test the significance of SIRT1 on cell proliferation, we transfected Sirt1-deficient mouse cells with expression vectors for normal FLAG-SIRT1 (WT) or FLAG-SIRT1 with the T530A/S540A mutation (AA). We found that the proliferation defects of Sirt1-/- MEFs (Fig. 7A, left-hand panel) and ES cells (Fig. 7B, left-hand panel) could be rescued by transfection of WT SIRT1, but not by the T530A/S540A double mutant (Fig. 7A-B, right-hand panels). These effects on proliferation were not due to large differences in protein concentration in transfected cells, as shown by western blot in Fig. 7C-D for MEFs, and ESCs, respectively.
###end p 46
###begin title 47
Phosphorylation of SIRT1 at Thr530 and Ser540 affects cell proliferation.
###end title 47
###begin p 48
###xml 22 25 22 25 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 35 38 35 38 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
Proliferation of Sirt1+/+ and Sirt1-/- MEFS (A) and ES cells (B) and in cells transfected with wild-type (WT) or mutant (AA) SIRT1. Representative experiments are shown. Each experiment was performed in triplicate and was repeated a minimum of two times. The differences were significant to varying degrees depending on the experiment and are indicated with an asterisk. Western blot analysis was used to ensure that the levels of expression of wild type or mutant SIRT1 proteins in transfected MEFs (C) and ESCs (D) were equivalent.
###end p 48
###begin p 49
###xml 279 283 279 283 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004020-Xu1">[31]</xref>
###xml 470 477 470 477 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 8A</bold>
###xml 470 477 470 477 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004020-g008"><bold>Fig. 8A</bold></xref>
###xml 630 637 630 637 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 8B</bold>
###xml 630 637 630 637 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004020-g008"><bold>Fig. 8B</bold></xref>
###xml 1187 1194 1187 1194 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 8C</bold>
###xml 1187 1194 1187 1194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004020-g008"><bold>Fig. 8C</bold></xref>
###xml 1293 1300 1293 1300 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 8B</bold>
###xml 1293 1307 1293 1307 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004020-g008"><bold>Fig. 8B</bold>; green</xref>
###xml 1451 1458 1451 1458 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 8A</bold>
###xml 1451 1458 1451 1458 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004020-g008"><bold>Fig. 8A</bold></xref>
###xml 757 762 <span type="species:ncbi:10090">mouse</span>
###xml 882 887 <span type="species:ncbi:9606">human</span>
To determine which phase of the cell cycle was affected by loss of Sirt1, we compared the cell cycle profiles of wild-type and Sirt1-deficient ES cells. Cells were stained with propidium iodide and an anti-phospho-histone H3 (Ser10) antibody that is detected only during mitosis [31]. Although we expected that phosphorylation by Cdk1, an M-phase kinase, would alter the percentage of Sirt1-/- ES cells in M-phase, there was no difference compared to Sirt1+/+ ES cells (Fig. 8A). We did find that Sirt1-/- ES cells have a small, but statistically significant, increase in the proportion of cells in S-phase compared to wild-type (Fig. 8B; compare mock-transfected Sirt+/+ and -/- ES cells). To determine if this was due to Cdk1-dependent phosphorylation of mouse Sirt1, we transfected wild-type and Sirt1-deficient ES cells with expression vectors encoding wild-type or mutant (AA) human SIRT1 and again analyzed the cell cycle by FACS. We found that wild-type SIRT1 could rescue the increase in S-phase cells, but the AA mutant could not. The percentages of cells in G1 and G2/M were also significantly different in Sirt1-deficient ES cells transfected with wild-type and mutant SIRT1 (Fig. 8C). Rescue of the G2/M-phase difference identified in mock-transfected Sirt1+/+ and Sirt1-/- cells (Fig. 8B; green) was due to rescue of G2 deficits by wild-type but not mutant SIRT1, consistent with our finding that M-phase in Sirt1-/- ES cells was normal (Fig. 8A). In summary, phosphorylation of SIRT1 by cyclinB/Cdk1 is necessary for progression through the cell cycle, apparently by facilitating entry into G2. Cell proliferation is impaired to the same extent by blocking Cdk1 phosphorylation of SIRT1 and by complete loss of SIRT1. Together with data indicating that dephosphorylation decreases SIRT1 deacetylase activity, these studies reveal a critical role for phosphorylation in regulating SIRT1 function.
###end p 49
###begin title 50
Phosphorylation of SIRT1 at Thr530 and Ser540 is required for normal cell cycle progression.
###end title 50
###begin p 51
###xml 58 61 58 61 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 78 81 78 81 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 270 273 270 273 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 283 286 283 286 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 396 397 396 397 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 437 440 437 440 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 455 458 455 458 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
A. Fraction of cells in M-phase of the cell cycle in Sirt1+/+ (blue) and Sirt1-/- (red) ES cells at three different time points in culture. The differences were not significant. B. Graphic representation of the fractions of cells in each phase of the cell cycle in Sirt1+/+ and Sirt1-/- ES cells transfected with empty vector (mock), WT-FLAG-SIRT1 (WT), or AA-FLAG-SIRT1 (AA) mutant. C. Table of p-values comparing mock-transfected Sirt1+/+ cells to Sirt1-/- cells transfected with empty vector (Mock), wild-type (WT), or mutant (AA) DNA. *p<0.05; **p<0.01.
###end p 51
###begin title 52
Discussion
###end title 52
###begin p 53
###xml 195 201 195 201 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
In this paper, we provide an explanation for our previous finding that increases in SIRT1 protein when cells are mitotically active are not the result of increased SIRT1 transcription (Sasaki T, et al. 2006). We have identified 13 serine and threonine residues in SIRT1 that are phosphorylated, and we demonstrated that one of the kinases that can phosphorylate SIRT1 is the cell cycle-dependent kinase Cdk1. Thus, post-transcriptional modification by phosphorylation appears to play a significant role in increasing the level of SIRT1 protein in cycling cells.
###end p 53
###begin p 54
###xml 395 410 395 410 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D. melanogaster</italic>
###xml 432 442 432 442 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. elegans</italic>
###xml 845 851 841 847 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 1534 1540 1530 1536 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 1733 1739 1729 1735 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 363 368 <span type="species:ncbi:9606">human</span>
###xml 395 410 <span type="species:ncbi:7227">D. melanogaster</span>
###xml 432 442 <span type="species:ncbi:6239">C. elegans</span>
###xml 783 788 <span type="species:ncbi:10090">mouse</span>
###xml 1478 1483 <span type="species:ncbi:9606">human</span>
###xml 1578 1583 <span type="species:ncbi:10090">mouse</span>
Some of the phosphorylated residues, cyclin-recognition motifs, and Cdk substrate motifs identified in our search are conserved among species. An in depth analysis revealed an interesting aspect of these conserved residues as they relate to organisms that, unlike mammals, consist mainly of post-mitotic cells as adults. The residue that corresponds to Ser540 in human SIRT1 is E (glutamate) in D. melanogaster and D (aspartate) in C. elegans. S-->D and S-->E mutations are commonly used as phospho-mimetics, suggesting that, in cells no longer undergoing mitosis, the function of SIRT1 affected by phosphorylation at this residue is essential. Loss of function, for example, might prevent cells from leaving the cell cycle. In fact, previous studies have shown that SIRT1-deficient mouse cells are resistant to replicative senescence (Chua KF, et al. 2005). In cells that must retain the ability to proliferate, SIRT1 activity would have to fluctuate according to whether or not the cells are actively dividing. By having that activity subject to cycles of phosphorylation and dephosphorylation regulated by the cell cycle, a feedback loop is set up whereby cyclin/Cdk complexes affect the activity of SIRT1, which in turn regulates proliferation. Thus, we found that wild-type SIRT1, but not the S540A/T530A mutant, was able to rescue the proliferation defect in SIRT1-/- MEFs and ESCs. This is consistent with a recent report demonstrating that forced expression of SIRT1 in human fibroblasts increased their growth rate (Huang J, et al. 2008). The fact that SIRT1-deficient mouse cells grow more slowly than their wild-type counterparts could in turn explain why they are resistant to replicative senescence in culture (Chua KF, et al. 2005). We would expect (although we did not test this) that enhancing proliferative competence of SIRT1-deficient cells by reintroducing wild-type SIRT1 would have the additional effect of reinstating replicative senescence.
###end p 54
###begin p 55
###xml 228 232 228 232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004020-Pflum1">[23]</xref>
###xml 234 238 234 238 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004020-deRuijter1">[24]</xref>
###xml 365 369 365 369 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004020-Grozinger1">[32]</xref>
###xml 371 375 371 375 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004020-Dequiedt1">[33]</xref>
###xml 473 477 473 477 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004020-Puntervoll1">[34]</xref>
###xml 701 711 701 711 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. elegans</italic>
###xml 711 715 711 715 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004020-Wang1">[35]</xref>
###xml 717 721 717 721 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004020-Berdichevsky1">[36]</xref>
###xml 498 503 <span type="species:ncbi:9606">human</span>
###xml 701 711 <span type="species:ncbi:6239">C. elegans</span>
Although this is the first extensive report on SIRT1 phosphorylation, other classes of HDACs are known to be regulated by phosphorylation. The activities and complex formation of HDAC1 and HDAC2 are regulated by phosphorylation [23], [24], and nucleo-cytoplasmic localization of HDAC4, HDAC5, and HDAC7 are regulated by 14-3-3 in a phosphorylation-dependent manner [32], [33]. According to functional motif predictions obtained through the Eukaryotic Linear Motif database [34], Ser26 and Ser27 of human SIRT1 are within interaction motif 2 of 14-3-3, and Ser172 and Ser173 are within interaction motif 3. Thus, it is possible that the interaction of SIRT1 with 14-3-3, which has been demonstrated in C. elegans[35], [36], is also regulated by phosphorylation in higher organisms.
###end p 55
###begin p 56
###xml 267 271 267 271 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004020-Obenauer1">[37]</xref>
###xml 287 291 287 291 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004020-Huang1">[38]</xref>
###xml 325 329 325 329 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004020-Puntervoll1">[34]</xref>
###xml 780 784 780 784 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004020-Dequiedt1">[33]</xref>
###xml 912 916 912 916 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004020-Parra1">[39]</xref>
###xml 1144 1151 1144 1151 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 5C</bold>
###xml 1144 1151 1144 1151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004020-g005"><bold>Fig. 5C</bold></xref>
The results of our study also imply that SIRT1 might undergo hierarchical levels of phosphorylation, with multiple phosphorylation sites cooperating to maximize subsequent phosphorylation events. According to functional motif predictions obtained through ScanSite () [37], KinasePhos () [38], and Eukaryotic Linear Motifs () [34] servers, the 13 phosphorylated residues of SIRT1 identified in this study match target motifs for ATM, CDK5, CK1, CK2, DNA-PK, ERK1, GSK3, IKK and MAPK, in addition to CDK1. Thus, any number of signaling cascades could influence SIRT1 function through the activity of various kinases and their accompanying phosphatases. It was recently reported for HDAC7, for example, that phosphorylation of Ser 155 is a prerequisite for phosphorylation of Ser181 [33] and that dephosphorylation by myosin phosphatase controls its nucleocytoplasmic shuttling and inhibits apoptosis in thymocytes [39]. The large number of potential kinases and the redundancy of kinases that can act on a single site could explain why we observed more robust phosphorylation of SIRT1 using a "mitotic kinase mix" compared to cyclinB/Cdk1 alone (Fig. 5C). The addition of other mitotic kinases, such as aurora kinase and polo kinase, present in the mix, significantly enhanced phosphorylation at Cdk1-specific sites.
###end p 56
###begin p 57
###xml 269 281 269 281 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fluor-de Lys</italic>
###xml 661 669 661 669 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 684 691 684 691 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 6B</bold>
###xml 684 691 684 691 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004020-g006"><bold>Fig. 6B</bold></xref>
###xml 1003 1009 1003 1009 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 2</bold>
###xml 1003 1009 1003 1009 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004020-g002"><bold>Fig. 2</bold></xref>
###xml 1393 1400 1393 1400 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 1C</bold>
###xml 1393 1400 1393 1400 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004020-g001"><bold>Fig. 1C</bold></xref>
###xml 1900 1904 1900 1904 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004020-North1">[40]</xref>
###xml 2068 2072 2068 2072 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004020-North1">[40]</xref>
###xml 2074 2078 2074 2078 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004020-Dryden1">[41]</xref>
When SIRT1 was dephosphorylated by treatment with non-specific phosphatases, there was a concomitant decrease in deacetylase activity. Mutation of the Cdk1 phosphorylation sites, however, did not lead to a reduction in deacetylase activity, at least as measured by the Fluor-de Lys deacetylase assay. One possible reason for this is that additional Cdk phosphorylation sites, such as Ser14, Ser26/27, Ser47 and Ser545, or any one of the other 11 phospho-residues, may have to be mutated before loss of Cdk1 phosphorylation will affect deacetylase activity. This could explain why the AA mutant showed a comparable amount of radioactive ATP incorporation in the in vitro kinase assay (Fig. 6B). Another possibility is that phosphorylation of certain residues may have positive influence on deacetylase activity, while others may have a negative or no influence. It should be noted that even relatively complete dephosphorylation by non-specific phosphatases did not totally abolish deacetylase activity (Fig. 2). Considering the fact that all the phosphorylation sites are located outside of the conserved catalytic domain, it is also possible that phosphorylation of these residues could affect enzyme activity indirectly. Based on predictions of 3D structure, Thr530 and Ser540 reside in the hinge region of SIRT1 between the conserved core domain and the C-terminal domain. As is clear from Fig. 1C, phosphorylation of these residues could alter the accessibility of substrate molecules to the catalytic groove of the deacetylase. This might be why there were significant differences in the effects of wild-type and mutant SIRT1 on biological phenotypes, such as cell proliferation and cell cycle profiles, despite there being no detectable difference in deacetylase activity between them in vitro. It should be noted that a similar result was observed following mutation of the Cdk1 site in SIRT2 [40], a cytoplasmic isoform of SIRT1. SIRT2 is phosphorylated on multiple residues during the G2/M transition and is dephosphorylated by CDC14A and CDC14B phosphatases [40], [41]. Thus, it appears that multiple sirtuins may be regulated by cell cycle-dependent kinases.
###end p 57
###begin p 58
###xml 326 330 326 330 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004020-Ubersax1">[42]</xref>
###xml 320 325 <span type="species:ncbi:4932">yeast</span>
###xml 656 661 <span type="species:ncbi:4932">yeast</span>
The targets that SIRT1 deacetylates in the context of mitosis remain undefined. CyclinB/Cdk1 kinase activity is tightly regulated and increases during M phase of the cell cycle, yet substrates vary and include proteins that regulate DNA replication, mitosis, spindle assembly, actin polarization, and other processes in yeast [42]. The identification of the molecular targets that are affected by SIRT1 phosphorylation, especially at sites modified by cell cycle-dependent kinases like Cdk1, will help to elucidate how changes in the level and activity of SIRT1 affect diverse processes such as growth and longevity in organisms ranging from single-celled yeast to mammals.
###end p 58
###begin title 59
Materials and Methods
###end title 59
###begin title 60
Cell culture
###end title 60
###begin p 61
###xml 5 8 5 8 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 18 21 18 21 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 545 548 542 545 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004020-Sasaki1">[9]</xref>
###xml 213 219 <span type="species:ncbi:10090">murine</span>
Sirt1-/- and Sirt1+/+ ES cells (gifts from Dr. F. Alt, Harvard) were cultured on gelatin-coated plates in DMEM supplemented with 15% FBS, L-glutamine, non-essential amino acids, nucleosides, beta-mercaptoethanol, murine leukemia inhibitory factor (LIF) (all from Millipore, Billerica, CA) and penicillin/streptomycin (Invitrogen, Carlsbad, CA). ES cells were cultured in the absence of feeder cells to get an accurate number for cell counting. 293T cells were purchased from ATCC (Manassas, VA). 293T cells were cultured as previously described [9]. For protein stability experiments, cells were cultured for 3 hours in the presence of the proteasome blocker MG132.
###end p 61
###begin title 62
Expression vector construction and transfection
###end title 62
###begin p 63
###xml 156 160 156 160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004020-Vaquero1">[43]</xref>
###xml 180 183 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
SIRT1 mutant expression vectors were generated by PCR mutagenesis using the SIRT1-expression vector pcDNA4/TO/FLAG-SIRT1 (a gift from Dr. D. Reinberg, NYU) [43] as a template. The CMV promoter of the pcDNA4/TO/FLAG-SIRT1 vector was replaced with the Pgk promoter at MluI/EcoRV sites to allow the expression of FLAG-SIRT1 in ES cells. For the empty pPGK vector, the pPGK-FLAGSIRT1 vector was digested with EcoRV and PmeI to remove FLAG-SIRT1 cDNA, and then blunt-end ligated. Plasmids were transfected using Lipofectamine 2000 (Invitrogen) following the manufacturer's protocol.
###end p 63
###begin title 64
Protein preparation and immunoprecipitation
###end title 64
###begin p 65
###xml 57 60 57 60 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004020-Sasaki1">[9]</xref>
###xml 1157 1161 1157 1161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004020-Gallo1">[44]</xref>
###xml 1289 1301 1289 1301 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fluor-de-Lys</italic>
Total cell lysates were prepared as previously described [9]. Immunoprecipitations of total cell lysates were performed with FLAG-M2 beads (Sigma-Aldrich), or anti-SIRT1 N-terminal polyclonal antibody (Millipore #07-131), anti-SIRT1 C-terminal polyclonal antibody AS-16 (Sigma-Aldrich #S5313) and protein G agarose (Millipore) for 2 hours or overnight. After washing 3 times with lysis buffer, SDS-PAGE and western blot analysis were performed. FLAG-SIRT1 protein was purified by incubating Benzonase-treated (Sigma-Aldrich) total cell lysates with anti-FLAG M2 beads for 2 hours or overnight, then washed 3 times with wash buffer (10% glycerol, 50 mM Tris pH 7, 150 mM NaCl), then eluted with FLAG peptide (Sigma-Aldrich). Further gel filtration was performed using HiLoad 6/16 Superdex 200 column and AKTA FPLC system (GE Healthcare, Piscataway, NJ) when necessary. Samples were concentrated by centrifugation through Microcon YM-10 filters (Millipore). GST-SIRT1 protein was purified as previously described using BL21-CodonPlus competent cells (Stratagene, La Jolla, CA) and the GST-SIRT1 expression vector pGEX2TK-SIRT1 (a gift from Dr. J. Smith, UVA) [44]. The purity of the proteins was tested by western blot and Coomassie blue staining, and the activities were measured using the Fluor-de-Lys deacetylase assay kit (Biomol International, Plymouth Meeting, PA). Antibodies used for the co-IP of endogenous proteins are as described for western blot analysis below.
###end p 65
###begin title 66
Western blot analysis
###end title 66
###begin p 67
###xml 1325 1334 1325 1334 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 4b</bold>
###xml 1325 1334 1325 1334 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004020-g004"><bold>Figure 4b</bold></xref>
###xml 303 307 <span type="species:ncbi:9925">Goat</span>
###xml 313 318 <span type="species:ncbi:10090">Mouse</span>
###xml 345 350 <span type="species:ncbi:10090">Mouse</span>
###xml 462 466 <span type="species:ncbi:9925">Goat</span>
###xml 472 478 <span type="species:ncbi:9986">Rabbit</span>
Samples were separated by SDS-PAGE using 10% or 4-20% Tris-HCl gels and transferred using standard protocols. To detect the antigen-antibody complexes, we used Western Pico or Femto chemiluminescence substrate (Pierce, Rockford, IL). The following antibodies were used: Peroxidase-conjugated AffiniPure Goat-anti-Mouse IgG and biotinylated anti-Mouse light chain (Jackson ImmunoResearch, West Grove, PA, #115-035-100, 1:10,000), Peroxidase-conjugated AffiniPure Goat anti-Rabbit IgG (Jackson ImmunoResearch #110-035-144, 1:10,000), anti-Cdc2 (Cdk1) mAb (Santa Cruz Biotechnology, Santa Cruz, CA, sc-8395, 1:1,000), anti-Cdk2 pAb (Abcam, Cambridge, MA, ab7954, 1:1,000), anti-Cdk4 pAb (Abcam ab2945, 1:1,000), anti-Cdk6 mAb (Abcam ab3126, 1:1,000), anti-cyclinA pAb (Abcam ab7956, 1:1,000), anti-cyclinB1 pAb (Abcam ab7957, 1:1,000), anti-FLAG M2 mAb (Sigma-Aldrich F3165, 1:2,000), anti-SIRT1 N-terminal polyclonal antibody (Millipore #07-131, 1:1,000), anti-SIRT1 C-terminal polyclonal antibody AS-16 (Sigma-Aldrich #S5313, 1:1,000), anti-SIRT1 monoclonal antibody 2G1/F7 (Millipore #05-707, 1:1,000), anti-phospho serine Cdk substrate antibody (Cell Signaling Technology, Danvers, MA, #2324, 1:2,000), anti-GAPDH antibody (Abcam ab8245, 1:5,000), and anti-pericentrin antibody (Covance, Richmond, CA, PRB-432C, 1:300). For Figure 4b, the ODYSSEY infrared imaging system (LI-COR, Lincoln, NE) was used to quantitate the percentage of phosphorylated SIRT1 in lambdappase-treated samples.
###end p 67
###begin title 68
Comparative analysis of SIRT1 amino acid sequences
###end title 68
###begin p 69
###xml 226 238 226 238 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Homo sapiens</italic>
###xml 259 274 259 274 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pan troglodytes</italic>
###xml 300 314 300 314 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Macaca mulatta</italic>
###xml 347 363 347 363 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Canis familiaris</italic>
###xml 391 401 391 401 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bos taurus</italic>
###xml 420 432 420 432 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mus musculus</italic>
###xml 452 469 452 469 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rattus norvegicus</italic>
###xml 491 504 491 504 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gallus gallus</italic>
###xml 530 553 530 553 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Drosophila melanogaster</italic>
###xml 577 599 577 599 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Caenorhabditis elegans</italic>
###xml 624 649 624 649 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Schizosaccharomyces pombe</italic>
###xml 680 704 680 704 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Saccharomyces cerevisiae</italic>
###xml 152 157 <span type="species:ncbi:9606">human</span>
###xml 226 238 <span type="species:ncbi:9606">Homo sapiens</span>
###xml 240 245 <span type="species:ncbi:9606">human</span>
###xml 259 274 <span type="species:ncbi:9598">Pan troglodytes</span>
###xml 276 286 <span type="species:ncbi:9598">chimpanzee</span>
###xml 300 314 <span type="species:ncbi:9544">Macaca mulatta</span>
###xml 347 363 <span type="species:ncbi:9615">Canis familiaris</span>
###xml 374 377 <span type="species:ncbi:9615">dog</span>
###xml 391 401 <span type="species:ncbi:9913">Bos taurus</span>
###xml 403 406 <span type="species:ncbi:9913">cow</span>
###xml 420 432 <span type="species:ncbi:10090">Mus musculus</span>
###xml 434 439 <span type="species:ncbi:10090">mouse</span>
###xml 452 469 <span type="species:ncbi:10116">Rattus norvegicus</span>
###xml 471 474 <span type="species:ncbi:10116">rat</span>
###xml 491 504 <span type="species:ncbi:9031">Gallus gallus</span>
###xml 506 513 <span type="species:ncbi:9031">chicken</span>
###xml 530 553 <span type="species:ncbi:7227">Drosophila melanogaster</span>
###xml 555 564 <span type="species:ncbi:7227">fruit fly</span>
###xml 577 599 <span type="species:ncbi:6239">Caenorhabditis elegans</span>
###xml 624 649 <span type="species:ncbi:4896">Schizosaccharomyces pombe</span>
###xml 651 664 <span type="species:ncbi:4896">fission yeast</span>
###xml 680 704 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
###xml 714 719 <span type="species:ncbi:4932">yeast</span>
Amino acid sequences of SIRT1 from various species were obtained from the NCBI database, and subjected to the BLAST 2 Sequence algorithm () against the human SIRT1 sequence. The following sequences were used for the analysis: Homo sapiens (human, NP_036370), Pan troglodytes (chimpanzee, XP_521490), Macaca mulatta (macaque monkey, XP_001087854), Canis familiaris (domestic dog, XP_546130), Bos taurus (cow, XP_869911), Mus musculus (mouse, AAR23928), Rattus norvegicus (rat, XP_001080493), Gallus gallus (chicken, NP_001004767), Drosophila melanogaster (fruit fly, AAC79684), Caenorhabditis elegans (round worm, CAA94364), Schizosaccharomyces pombe (fission yeast, CAG47122) and Saccharomyces cerevisiae (budding yeast, NP_010242).
###end p 69
###begin title 70
ProQ Diamond phospho-protein staining
###end title 70
###begin p 71
After protein samples were separated by SDS-PAGE and transferred to nitrocellulose membrane, the membrane was stained with Pro-Q Diamond phosphoprotein staining kit (Invitrogen P-33356) following the manufacturer's protocol.
###end p 71
###begin title 72
Phospho-peptide mapping by mass spectrometry
###end title 72
###begin p 73
###xml 57 61 57 61 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004020-Abbas1">[45]</xref>
Phospho-peptide mapping was done as previously described [45]. The gel band containing FLAG-SIRT1 was identified by silver stain, cut out, and the peptides generated by trypsin treatment. Peptides were analyzed using the LC-MS system.
###end p 73
###begin title 74
###xml 25 30 <span type="species:ncbi:9606">human</span>
Structure prediction for human SIRT1
###end title 74
###begin p 75
###xml 406 415 406 415 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ab initio</italic>
###xml 532 536 532 536 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004020-Humphrey1">[46]</xref>
###xml 33 38 <span type="species:ncbi:9606">human</span>
Protein sequence information for human SIRT1 (NP_036370) was obtained from the PubMed protein database. This protein sequence was used to derive a full chain protein structure prediction on the Robetta server (Baker Laboratory, ). The Robetta server subjected the SIRT1 sequence first to the Ginzu protocol that determined putative domain structures and then modeled those domains either by homology or by ab initio modeling. Out of ten model predictions, the best fitting was chosen to illustrate the full chain SIRT1. VMD1.8.6 () [46] was used for graphical illustration of the predicted structure and the phosphorylation sites.
###end p 75
###begin title 76
Phosphatase preparations and treatments
###end title 76
###begin p 77
###xml 361 362 355 356 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 364 365 358 359 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 13 17 <span type="species:ncbi:9913">calf</span>
Solutions of calf intestinal phosphatase (New England Biolab, Ipswich, MA) or lambda phosphatase (a gift from Dr. D. Brautigan, UVA) were prepared and incubated with FLAG-SIRT1 samples at 1:1 volume for 1 hour at 37degreesC unless otherwise indicated. Phosphatase activity was blocked by adding phosphatase inhibitor cocktails I & II (Sigma-Aldrich) or 10 mM Na3VO4 (Sigma-Aldrich).
###end p 77
###begin title 78
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vitro</italic>
In vitro kinase assay
###end title 78
###begin p 79
###xml 69 70 69 70 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 156 158 144 146 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 192 199 180 187 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Xenopus</italic>
###xml 803 807 791 795 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004020-Li1">[30]</xref>
###xml 192 199 <span type="species:ncbi:8355">Xenopus</span>
Kinase reactions were performed in 20 mM Tris HCl (pH 7.5), 1 mM MgCl2, 25 mM KCl, 1 mM DTT, and 40 microg/mL BSA, with 100 microM of ATP spiked with gamma-32P-ATP. CyclinB/Cdk1 purified from Xenopus was used with 5-10 pmole of substrate. Samples were harvested at each time point, and reactions quenched with 6x-sample buffer. Samples were separated by SDS-PAGE and stained with Bio-Safe Coomassie (Biorad). Gels were photographed with ChemiImager Ready (IMGEN technologies, Alexandria, VA). After autoradiography, each protein band was cut out of the gel and the radioactivity in the sample measured using a Beckman LS 6000SE scintillation counter (Beckman Coulter, Fullerton, CA). "Mitotic kinase mix" (a gift from Dr. D. Brautigan, UVA) was prepared according to the protocol described in reference [30].
###end p 79
###begin title 80
###xml 0 12 0 12 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fluor-de Lys</italic>
Fluor-de Lys deacetylase assay
###end title 80
###begin p 81
###xml 0 12 0 12 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fluor-de Lys</italic>
Fluor-de Lys deacetylase assay kit (Biomol International) was used to analyze deacetylase activities in various SIRT1 preparations, using a slight modification of the protocol recommended by the supplier to adjust for the detection range of the fluorometer. Nicotinamide was added to the reaction at the concentration of 2 mM when necessary. The final fluorescence was measured in a Fluoroskan Ascent FL fluorometer (Thermo Fisher Scientific, Waltham, MA).
###end p 81
###begin title 82
Cell proliferation assay
###end title 82
###begin p 83
###xml 58 59 58 59 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 294 295 290 291 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 610 611 606 607 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 756 759 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
Lipofectamine 2000 (Invitrogen) was used to transfect 1x106 ES cells with 2 microg of empty vector or expression vectors for FLAG-SIRT1 with or without the T530A and S540A double mutation. All vectors carried the PGK-promoter to support expression in ES-cells. 24 hours after transfection, 2x104 cells/well were re-plated onto gelatin-coated 12-well plates, and cells were counted 24, 36, 48, 60, and 72 hours after replating. Each group consisted of triplicates and the experiment was done three times, and the average and the standard error of the number of cells in each well were calculated. For MEFs, 5x104 cells/well at passage 3 (split at 1:4 at each passage, used prior to immortalization) were transfected with expression constructs driven by the CMV promoter, and done in triplicate.
###end p 83
###begin title 84
Cell cycle analysis
###end title 84
###begin p 85
###xml 134 135 134 135 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 467 471 461 465 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004020-Xu1">[31]</xref>
###xml 377 381 <span type="species:ncbi:9925">goat</span>
###xml 387 393 <span type="species:ncbi:9986">rabbit</span>
Cells were harvested by trypsinization, washed with phosphate-buffered saline (PBS), and fixed in 70% ethanol at a concentration of 106 cells per ml at -20degreesC for 2 hours or overnight. After fixation, cells were stained with propidium iodide (Sigma-Aldrich) and anti-phospho histone H3 (Ser10) mitosis marker antibody (Millipore, 1:1,000) followed by Alexa 488-conjugated goat anti-rabbit immunoglobulin G antibody (Invitrogen, 1:2,000), as previously described [31]. Analyses were done at the University of Virginia Flow Cytometry Facility and cell cycle distributions were analyzed using ModiFit LT version 3.1 software (Verity Software House, Topsham, ME). The number of cells in the G2 phase of the cell cycle was calculated by subtracting the number of cells in M phase (determined by phospho-H3 staining) from the number of cells in G2/M phase (determined by PI staining).
###end p 85
###begin p 86
###xml 689 692 689 692 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 702 705 702 705 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
We thank Dr. David Brautigan (Center for Cell Signaling at the University of Virginia) for providing lambda phosphatase and mitotic kinase mix and for many helpful discussions. We thank Dr. Jeffrey S. Smith (Department of Biochemistry and Molecular Genetics at the University of Virginia) for pGEX2TK-SIRT1, Dr. Scott Zeitlin (Department of Neuroscience, University of Virginia) for the Pgk-Neo vector, Dr. Danny Reinberg (Howard Hughes Medical Institute, Smilow Research Center, Department of Biochemistry, New York University, New York, NY) for pcDNA4/TO/FLAG-SIRT1, and Dr. Fredrick Alt (Howard Hughes Medical Institute, Department of Genetics, Harvard University, Boston, MA) for Sirt1+/+ and Sirt1-/- ES cells. We thank Dr. Thomas Sturgill (Department of Pharmacology, University of Virginia) for many helpful and provocative discussions. We thank Dr. Jeremy Tuttle (Department of Neuroscience at the University of Virginia) for the use of Fluoroskan Ascent FL and Dr. Terry Turner (Department of Urology at the University of Virginia) for the use of Eppendorf Centrifuge 5810R. We thank the mass spectrometry and flow cytometry core facilities at the University of Virginia for providing excellent services.
###end p 86
###begin title 87
References
###end title 87
###begin article-title 88
Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase.
###end article-title 88
###begin article-title 89
The silencing protein SIR2 and its homologs are NAD-dependent protein deacetylases.
###end article-title 89
###begin article-title 90
A phylogenetically conserved NAD+-dependent protein deacetylase activity in the Sir2 protein family.
###end article-title 90
###begin article-title 91
###xml 57 81 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
The SIR2/3/4 complex and SIR2 alone promote longevity in Saccharomyces cerevisiae by two different mechanisms.
###end article-title 91
###begin article-title 92
###xml 53 75 <span type="species:ncbi:6239">Caenorhabditis elegans</span>
Increased dosage of a sir-2 gene extends lifespan in Caenorhabditis elegans.
###end article-title 92
###begin article-title 93
Sir2 mediates longevity in the fly through a pathway related to calorie restriction.
###end article-title 93
###begin article-title 94
###xml 25 30 <span type="species:ncbi:9606">human</span>
###xml 58 63 <span type="species:ncbi:4932">yeast</span>
Characterization of five human cDNAs with homology to the yeast SIR2 gene: Sir2-like proteins (sirtuins) metabolize NAD and may have protein ADP-ribosyltransferase activity.
###end article-title 94
###begin article-title 95
Phylogenetic classification of prokaryotic and eukaryotic Sir2-like proteins.
###end article-title 95
###begin article-title 96
Progressive loss of SIRT1 with cell cycle withdrawal.
###end article-title 96
###begin article-title 97
SIRT1 sumoylation regulates its deacetylase activity and cellular response to genotoxic stress.
###end article-title 97
###begin article-title 98
Large-scale characterization of HeLa cell nuclear phosphoproteins.
###end article-title 98
###begin article-title 99
###xml 81 85 <span type="species:ncbi:10090">mice</span>
Developmental defects and p53 hyperacetylation in Sir2 homolog (SIRT1)-deficient mice.
###end article-title 99
###begin article-title 100
The mammalian SIR2alpha protein has a role in embryogenesis and gametogenesis.
###end article-title 100
###begin article-title 101
Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes.
###end article-title 101
###begin article-title 102
Resveratrol Improves Mitochondrial Function and Protects against Metabolic Disease by Activating SIRT1 and PGC-1alpha.
###end article-title 102
###begin article-title 103
###xml 44 48 <span type="species:ncbi:10090">mice</span>
Resveratrol improves health and survival of mice on a high-calorie diet.
###end article-title 103
###begin article-title 104
DBC1 is a negative regulator of SIRT1.
###end article-title 104
###begin article-title 105
Negative regulation of the deacetylase SIRT1 by DBC1.
###end article-title 105
###begin article-title 106
Active regulator of SIRT1 cooperates with SIRT1 and facilitates suppression of p53 activity.
###end article-title 106
###begin article-title 107
###xml 79 103 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
Four genes responsible for a position effect on expression from HML and HMR in Saccharomyces cerevisiae.
###end article-title 107
###begin article-title 108
###xml 49 55 <span type="species:ncbi:9606">humans</span>
The SIR2 gene family, conserved from bacteria to humans, functions in silencing, cell cycle progression, and chromosome stability.
###end article-title 108
###begin article-title 109
Mitotic kinases as regulators of cell division and its checkpoints.
###end article-title 109
###begin article-title 110
Histone deacetylase 1 phosphorylation promotes enzymatic activity and complex formation.
###end article-title 110
###begin article-title 111
Histone deacetylases (HDACs): characterization of the classical HDAC family.
###end article-title 111
###begin article-title 112
A bipartite substrate recognition motif for cyclin-dependent kinases.
###end article-title 112
###begin article-title 113
Use of an oriented peptide library to determine the optimal substrates of protein kinases.
###end article-title 113
###begin article-title 114
The design of peptide-based substrates for the cdc2 protein kinase.
###end article-title 114
###begin article-title 115
###xml 42 47 <span type="species:ncbi:9606">human</span>
Substrate specificity of CDC2 kinase from human HeLa cells as determined with synthetic peptides and molecular modeling.
###end article-title 115
###begin article-title 116
###xml 45 69 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan.
###end article-title 116
###begin article-title 117
Phosphorylation of the Pro-X-Thr-Pro site in phosphatase inhibitor-2 by cyclin-dependent protein kinase during M-phase of the cell cycle.
###end article-title 117
###begin article-title 118
Involvement of Brca1 in S-phase and G(2)-phase checkpoints after ionizing irradiation.
###end article-title 118
###begin article-title 119
Regulation of histone deacetylase 4 and 5 and transcriptional activity by 14-3-3-dependent cellular localization.
###end article-title 119
###begin article-title 120
New role for hPar-1 kinases EMK and C-TAK1 in regulating localization and activity of class IIa histone deacetylases.
###end article-title 120
###begin article-title 121
ELM server: A new resource for investigating short functional sites in modular eukaryotic proteins.
###end article-title 121
###begin article-title 122
###xml 0 10 <span type="species:ncbi:6239">C. elegans</span>
C. elegans 14-3-3 proteins regulate life span and interact with SIR-2.1 and DAF-16/FOXO.
###end article-title 122
###begin article-title 123
###xml 0 10 <span type="species:ncbi:6239">C. elegans</span>
C. elegans SIR-2.1 interacts with 14-3-3 proteins to activate DAF-16 and extend life span.
###end article-title 123
###begin article-title 124
Scansite 2.0: Proteome-wide prediction of cell signaling interactions using short sequence motifs.
###end article-title 124
###begin article-title 125
KinasePhos: a web tool for identifying protein kinase-specific phosphorylation sites.
###end article-title 125
###begin article-title 126
Myosin phosphatase dephosphorylates HDAC7, controls its nucleocytoplasmic shuttling, and inhibits apoptosis in thymocytes.
###end article-title 126
###begin article-title 127
Mitotic Regulation of SIRT2 by Cyclin-dependent Kinase 1-dependent Phosphorylation.
###end article-title 127
###begin article-title 128
###xml 9 14 <span type="species:ncbi:9606">human</span>
Role for human SIRT2 NAD-dependent deacetylase activity in control of mitotic exit in the cell cycle.
###end article-title 128
###begin article-title 129
Targets of the cyclin-dependent kinase Cdk1.
###end article-title 129
###begin article-title 130
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human SirT1 interacts with histone H1 and promotes formation of facultative heterochromatin.
###end article-title 130
###begin article-title 131
Nicotinamide clearance by Pnc1 directly regulates Sir2-mediated silencing and longevity.
###end article-title 131
###begin article-title 132
Autocatalytic phosphorylation of CDK2 at the activating Thr160.
###end article-title 132
###begin article-title 133
VMD: visual molecular dynamics.
###end article-title 133
###begin p 134
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 134
###begin p 135
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This work was supported by PHS grant NIH AG026094 (H.S.) and NIH GM53163 and GM74942 (W.M.). H.S. is a fellow of the Ellison Foundation for Medical Research. The flow cytometry core facility is supported by Cancer Center Support Grant P30 CA45579.
###end p 135

